LSB Industries, Inc. Reports Operating Results for the 2020 Fourth Quarter
Fourth Quarter and Full Year 2020 Highlights
- Record total recordable injury rate (TRIR) of 1.06 for 2020, an improvement of 58% compared to 2019
-
Net sales of
$88.9 million reflects a 31% increase from stronger sales volumes, partially offset by a 11% decrease from weaker pricing relative to the prior year fourth quarter -
Adjusted EBITDA(1) of
$10.4 million reflects a$16.3 million benefit from stronger production and sales volumes, partially offset by a$9.6 million net impact from weaker pricing and$2.2 million from COVID-19’s impact on demand, relative to the prior year fourth quarter - Full year production volume records for ammonia of 827,000 tons and for UAN of 501,000 tons
- 64% increase in fertilizer sales volumes, including a 105% increase in UAN sales volumes, versus the fourth quarter of 2019
-
Total liquidity of approximately
$58 million as ofDecember 31, 2020
“We delivered fourth quarter 2020 results largely in-line with our expectations headed into the period,” stated
“The fourth quarter capped off our best year of operating performance across our three facilities in our company’s history. We delivered record production volumes for ammonia and UAN for full year 2020, reflecting a return on the investments we’ve made in plant reliability and product upgrading capabilities over the last several years as well as our focus on continuous improvement in our manufacturing operations. We also benefitted from the absence of any turnaround activity in 2020 as compared to 2019. Overall, we were pleased with the performance of our plants in 2020 and believe that we will generate further improvement in operating rates and production volumes in 2021.”
“Lastly, consistent with the global focus on reducing carbon emissions, we are currently working on developing a strategy to enter the clean energy market through the production of “green ammonia.” We view this as a growth platform for our business and believe that current ammonia producers are best positioned to be leaders in this market as it develops, due to our ability to leverage our existing knowledge in ammonia manufacturing, handling, storage and logistics. We are very excited about the opportunities ahead of us in 2021 and look forward to providing updates on key initiatives and developments as we move through the year.”
(1) This is a Non-GAAP measure. Refer to the Non-GAAP Reconciliation section. |
Three Months Ended |
|||||||||||||||
2020 |
2019 |
||||||||||||||
(Dollars in thousands) |
|||||||||||||||
|
|
Sector Mix |
|
Sector Mix |
% Change |
||||||||||
Agricultural |
|
$ |
41,595 |
|
47 |
% |
|
$ |
32,851 |
|
45 |
% |
|
27 |
% |
Industrial |
|
|
35,887 |
|
40 |
% |
|
|
34,064 |
|
46 |
% |
|
5 |
% |
Mining |
|
|
11,421 |
|
13 |
% |
|
|
6,981 |
|
9 |
% |
|
64 |
% |
$ |
88,903 |
$ |
73,896 |
20 |
% |
Comparison of 2020 to 2019 quarterly periods:
-
Net sales of our agricultural products increased during the quarter relative to the prior year period driven by stronger volumes for all of our products, particularly UAN, which benefited from higher production at our
Pryor facility resulting from the installation of a new Urea reactor in the fourth quarter of 2019 and the absence of turnaround activity in the 2020 fourth quarter compared to the prior year period; in November of 2019,Pryor was down for two weeks as a turnaround was concluded. Partially offsetting the increased production volume was continued weaker pricing for HDAN, UAN and agricultural ammonia. - Net sales of our industrial and mining products, other than Nitric acid, increased modestly as several key end markets for our products, including automotive, home building, power generation, and mining markets have been gradually recovering, although not yet reaching pre-pandemic levels. Nitric Acid sales continue to be impacted by pandemic related market weakness.
- The year-over-year change in operating loss and adjusted EBITDA was primarily the result of the higher volumes and improved fixed cost absorption partially offset by weaker selling prices, particularly for agricultural products.
The following tables provide key sales metrics for our Agricultural products:
|
|
Three Months Ended |
|||||
Product (tons sold) |
|
2020 |
|
2019 |
|
% Change |
|
Urea ammonium nitrate (UAN) |
|
131,665 |
|
64,298 |
|
105 |
% |
High density ammonium nitrate (HDAN) |
|
70,987 |
|
58,603 |
|
21 |
% |
Ammonia |
|
28,293 |
|
17,071 |
|
66 |
% |
Other |
|
2,997 |
|
2,516 |
|
19 |
% |
|
|
233,942 |
|
142,488 |
|
64 |
% |
Average Selling Prices (price per ton) (A) |
|
|
|
|
|
|
|||
UAN |
|
$ |
132 |
|
$ |
161 |
|
(18 |
)% |
HDAN |
|
$ |
159 |
|
$ |
201 |
|
(21 |
)% |
Ammonia |
|
$ |
210 |
|
$ |
253 |
|
(17 |
)% |
(A) Average selling prices represent “net back” prices which are calculated as sales less freight expenses divided by product sales volume in tons. |
The following table indicates the volumes sold of our major Industrial products:
|
|
Three Months Ended |
|||||||
Product (tons sold) |
|
2020 |
|
2019 |
|
% Change |
|||
Ammonia |
|
|
68,483 |
|
|
64,868 |
|
6 |
% |
Nitric acid |
|
|
29,270 |
|
|
29,594 |
|
(1 |
)% |
Other Industrial Products |
|
|
14,369 |
|
|
9,839 |
|
46 |
% |
|
|
|
112,122 |
|
|
104,301 |
|
7 |
% |
Tampa Ammonia Benchmark (price per metric ton) |
$ |
239 |
$ |
255 |
(6 |
)% |
The following table indicates the volumes sold of our major Mining products:
|
|
Three Months Ended |
|||||||
Product (tons sold) |
|
2020 |
|
2019 |
|
% Change |
|||
LDAN/HDAN/AN solution |
|
|
44,970 |
|
|
29,015 |
|
55 |
% |
Input Costs |
|
|
|
|
|
|
|||
Average natural gas cost/MMBtu |
|
$ |
2.46 |
|
$ |
2.47 |
|
0 |
% |
Financial Position and Capital Expenditures
As of
Interest expense for the fourth quarter of 2020 was
Capital expenditures were approximately
Volume Outlook
The Company’s outlook for sales volumes for the full year 2021 are as follows:
Products |
Full Year 2021 Sales* (tons) |
Full Year Actual 2020 Sales (tons) |
Agriculture: |
|
|
UAN |
480,000 – 500,000 |
499,000 |
HDAN |
280,000 – 300,000 |
293,000 |
Ammonia |
70,000 – 90,000 |
97,000 |
|
|
|
Industrial, Mining and Other: |
|
|
Ammonia |
240,000 – 260,000 |
269,000 |
AN, Nitric, and Other |
400,000 – 420,000 |
303,000 |
Sulfuric Acid |
145,000 – 165,000 |
146,000 |
*2021 sales volumes forecast reflects turnaround of approximately 30 days for the |
Conference Call
LSB’s management will host a conference call covering the fourth quarter results on
To listen to a webcast of the call, please go to the Company’s website at www.lsbindustries.com at least 15 minutes prior to the conference call to download and install any necessary audio software. If you are unable to listen live, the conference call webcast will be archived on the Company’s website.
Forward-Looking Statements
Statements in this release that are not historical are forward-looking statements within the meaning of the
Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Unless otherwise required by applicable laws, we undertake no obligation to update or revise any forward-looking statements, whether because of new information or future developments.
See Accompanying Tables
Financial Highlights
Three and Twelve Months Ended |
||||||||||||||||
|
|
|
|
|
||||||||||||
|
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||
|
|
(In Thousands, Except Per Share Amounts) |
||||||||||||||
Net sales |
|
$ |
88,903 |
|
|
$ |
73,896 |
|
|
$ |
351,316 |
|
|
$ |
365,070 |
|
Cost of sales |
|
|
92,368 |
|
|
|
86,173 |
|
|
|
334,268 |
|
|
|
360,085 |
|
Gross profit (loss) |
|
|
(3,465 |
) |
|
|
(12,277 |
) |
|
|
17,048 |
|
|
|
4,985 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Selling, general and administrative expense |
|
|
6,506 |
|
|
|
9,467 |
|
|
|
32,084 |
|
|
|
34,172 |
|
Other expense, net |
|
|
259 |
|
|
|
9,532 |
|
|
|
499 |
|
|
|
9,904 |
|
Operating loss |
|
|
(10,230 |
) |
|
|
(31,276 |
) |
|
|
(15,535 |
) |
|
|
(39,091 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Interest expense, net |
|
|
12,606 |
|
|
|
12,080 |
|
|
|
51,115 |
|
|
|
46,389 |
|
Non-operating other expense (income), net |
|
|
597 |
|
|
|
(534 |
) |
|
|
10 |
|
|
|
(1,139 |
) |
Loss before benefit for income taxes |
|
|
(23,433 |
) |
|
|
(42,822 |
) |
|
|
(66,660 |
) |
|
|
(84,341 |
) |
Benefit for income taxes |
|
|
(1,741 |
) |
|
|
(15,108 |
) |
|
|
(4,749 |
) |
|
|
(20,924 |
) |
Net loss |
|
|
(21,692 |
) |
|
|
(27,714 |
) |
|
|
(61,911 |
) |
|
|
(63,417 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Dividends on convertible preferred stocks |
|
|
75 |
|
|
|
75 |
|
|
|
300 |
|
|
|
300 |
|
Dividends on Series E redeemable preferred stock |
|
|
9,297 |
|
|
|
8,120 |
|
|
|
35,182 |
|
|
|
30,729 |
|
Accretion of Series E redeemable preferred stock |
|
|
509 |
|
|
|
502 |
|
|
|
2,026 |
|
|
|
1,995 |
|
Net loss attributable to common stockholders |
|
$ |
(31,573 |
) |
|
$ |
(36,411 |
) |
|
$ |
(99,419 |
) |
|
$ |
(96,441 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic and dilutive net loss per common share |
|
$ |
(1.12 |
) |
|
$ |
(1.30 |
) |
|
$ |
(3.53 |
) |
|
$ |
(3.44 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Balance Sheets |
||||||||
|
|
|
||||||
|
|
2020 |
|
2019 |
||||
|
|
(In Thousands) |
|
|||||
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
16,264 |
|
|
$ |
22,791 |
|
Accounts receivable |
|
|
42,929 |
|
|
|
40,203 |
|
Allowance for doubtful accounts |
|
|
(378 |
) |
|
|
(261 |
) |
Accounts receivable, net |
|
|
42,551 |
|
|
|
39,942 |
|
Inventories: |
|
|
|
|
|
|
|
|
Finished goods |
|
|
17,778 |
|
|
|
21,738 |
|
Raw materials |
|
|
1,795 |
|
|
|
1,573 |
|
Total inventories |
|
|
19,573 |
|
|
|
23,311 |
|
Supplies, prepaid items and other: |
|
|
|
|
|
|
|
|
Prepaid insurance |
|
|
12,315 |
|
|
|
11,837 |
|
Precious metals |
|
|
6,787 |
|
|
|
5,568 |
|
Supplies |
|
|
25,288 |
|
|
|
24,689 |
|
Other |
|
|
6,802 |
|
|
|
2,735 |
|
Total supplies, prepaid items and other |
|
|
51,192 |
|
|
|
44,829 |
|
Total current assets |
|
|
129,580 |
|
|
|
130,873 |
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
891,198 |
|
|
|
936,474 |
|
|
|
|
|
|
|
|
|
|
Other assets: |
|
|
|
|
|
|
|
|
Operating lease assets |
|
|
26,403 |
|
|
|
15,330 |
|
Intangible and other assets, net |
|
|
6,121 |
|
|
|
5,812 |
|
|
|
|
32,524 |
|
|
|
21,142 |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,053,302 |
|
|
$ |
1,088,489 |
|
Consolidated Balance Sheets (continued) |
||||||||
|
|
|
||||||
|
|
2020 |
|
2019 |
||||
|
|
(In Thousands) |
|
|||||
Liabilities and Stockholders' Equity |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
46,551 |
|
|
$ |
58,477 |
|
Short-term financing |
|
|
13,576 |
|
|
|
9,929 |
|
Accrued and other liabilities |
|
|
30,367 |
|
|
|
25,484 |
|
Current portion of long-term debt |
|
|
16,801 |
|
|
|
9,410 |
|
Total current liabilities |
|
|
107,295 |
|
|
|
103,300 |
|
|
|
|
|
|
|
|
|
|
Long-term debt, net |
|
|
467,389 |
|
|
|
449,634 |
|
|
|
|
|
|
|
|
|
|
Noncurrent operating lease liabilities |
|
|
19,845 |
|
|
|
11,404 |
|
|
|
|
|
|
|
|
|
|
Other noncurrent accrued and other liabilities |
|
|
6,090 |
|
|
|
6,214 |
|
|
|
|
|
|
|
|
|
|
Deferred income taxes |
|
|
30,939 |
|
|
|
35,717 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable preferred stocks: |
|
|
|
|
|
|
|
|
Series E 14% cumulative, redeemable Class C preferred stock, no par value, |
|
|
|
|
|
|
|
|
210,000 shares issued; 139,768 outstanding; aggregate liquidation preference |
||||||||
of |
272,101 |
234,893 |
||||||
Series F redeemable Class C preferred stock, no par value, 1 share issued |
|
|
|
|
|
|
||
and outstanding; aggregate liquidation preference of |
— |
— |
||||||
|
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
|
Series B 12% cumulative, convertible preferred stock, |
|
|
|
|
|
|
|
|
shares issued and outstanding; aggregate liquidation preference |
||||||||
of |
2,000 |
2,000 |
||||||
Series D 6% cumulative, convertible Class C preferred stock, no par value; |
|
|
|
|
|
|
|
|
1,000,000 shares issued and outstanding; aggregate liquidation preference |
||||||||
of |
1,000 |
1,000 |
||||||
Common stock, |
|
|
|
|
|
|
|
|
31,283,210 shares issued (31,283,210 shares at |
3,128 |
3,128 |
||||||
Capital in excess of par value |
|
|
198,215 |
|
|
|
196,833 |
|
Retained earnings (accumulated deficit) |
|
|
(41,487 |
) |
|
|
57,632 |
|
|
|
|
162,856 |
|
|
|
260,593 |
|
Less treasury stock, at cost: |
|
|
|
|
|
|
|
|
Common stock, 2,074,565 shares (2,009,566 shares at |
|
|
13,213 |
|
|
|
13,266 |
|
Total stockholders' equity |
|
|
149,643 |
|
|
|
247,327 |
|
|
|
$ |
1,053,302 |
|
|
$ |
1,088,489 |
|
Non-GAAP Reconciliation
This news release includes certain “non-GAAP financial measures” under the rules of the
EBITDA Reconciliation
EBITDA is defined as net income (loss) plus interest expense, plus loss on extinguishment of debt, plus depreciation and amortization (D&A) (which includes D&A of property, plant and equipment and amortization of intangible and other assets), plus provision for income taxes. We believe that certain investors consider EBITDA a useful means of measuring our ability to meet our debt service obligations and evaluating our financial performance. EBITDA has limitations and should not be considered in isolation or as a substitute for net income, operating income, cash flow from operations or other consolidated income or cash flow data prepared in accordance with GAAP. Because not all companies use identical calculations, this presentation of EBITDA may not be comparable to a similarly titled measure of other companies. The following table provides a reconciliation of net income (loss) to EBITDA for the periods indicated.
LSB Consolidated ($ in thousands) |
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
2020 |
|
|
|
2019 |
|
|
|
2020 |
|
|
|
2019 |
|
|
|
|||||||||||||||
Net loss |
$ |
(21,692 |
) |
|
$ |
(27,714 |
) |
|
$ |
(61,911 |
) |
|
$ |
(63,417 |
) |
Plus: |
|
|
|
|
|
|
|
||||||||
Interest expense |
|
12,606 |
|
|
|
12,080 |
|
|
|
51,115 |
|
|
|
46,389 |
|
Depreciation and amortization |
|
17,939 |
|
|
|
17,064 |
|
|
|
70,841 |
|
|
|
69,574 |
|
Benefit for income taxes |
|
(1,741 |
) |
|
|
(15,108 |
) |
|
|
(4,749 |
) |
|
|
(20,924 |
) |
EBITDA |
$ |
7,112 |
|
|
$ |
(13,678 |
) |
|
$ |
55,296 |
|
|
$ |
31,622 |
|
Non-GAAP Reconciliation (continued)
Adjusted EBITDA
Adjusted EBITDA is reported to show the impact of one time/non-cash or non-operating items-such as, loss (gain) on sale of a business and other property and equipment, one-time income or fees, certain fair market value (FMV) adjustments, non-cash stock-based compensation, and consulting costs associated with reliability and purchasing initiatives (Initiatives). We historically have performed Turnaround activities on an annual basis; however, we have moved towards extending Turnarounds to a two or three-year cycle. Rather than being capitalized and amortized over the period of benefit, our accounting policy is to recognize the costs as incurred. Given these Turnarounds are essentially investments that provide benefits over multiple years, they are not reflective of our operating performance in a given year. As a result, we believe it is more meaningful for investors to exclude them from our calculation of adjusted EBITDA used to assess our performance. We believe that the inclusion of supplementary adjustments to EBITDA is appropriate to provide additional information to investors about certain items. The following tables provide reconciliations of EBITDA excluding the impact of the supplementary adjustments.
LSB Consolidated ($ in thousands) |
Three Months Ended |
Twelve Months Ended |
|||||||||||||
|
2020 |
|
|
|
2019 |
|
|
|
2020 |
|
|
|
2019 |
|
|
|
|||||||||||||||
EBITDA: |
$ |
7,112 |
|
|
$ |
(13,678 |
) |
|
$ |
55,296 |
|
|
$ |
31,622 |
|
Stock-based compensation |
|
134 |
|
|
|
421 |
|
|
|
1,761 |
|
|
|
2,220 |
|
Severance costs |
|
— |
|
|
|
615 |
|
|
|
— |
|
|
|
615 |
|
Unrealized loss on commodity contracts |
|
1,743 |
|
|
|
— |
|
|
|
1,205 |
|
|
|
— |
|
Legal fees (Leidos) |
|
572 |
|
|
|
3,843 |
|
|
|
5,715 |
|
|
|
9,601 |
|
Loss on disposal of assets and other |
|
312 |
|
|
|
10,564 |
|
|
|
921 |
|
|
|
11,221 |
|
FMV adjustment on preferred stock embedded derivatives |
|
562 |
|
|
|
(437 |
) |
|
|
(55 |
) |
|
|
(558 |
) |
Consulting costs associated with Initiatives |
|
(20 |
) |
|
|
502 |
|
|
|
558 |
|
|
|
1,414 |
|
Turnaround costs |
|
31 |
|
|
|
5,373 |
|
|
|
76 |
|
|
|
13,210 |
|
Adjusted EBITDA |
$ |
10,446 |
|
|
$ |
7,203 |
|
|
$ |
65,477 |
|
|
$ |
69,345 |
|
Agricultural Sales Price Reconciliation
The following table provides a reconciliation of total agricultural net sales as reported under GAAP in our consolidated financial statement reconciled to netback sales which is calculated as net sales less freight expenses. We believe this provides a relevant industry comparison among our peer group.
Three Months Ended |
|
Twelve Months Ended |
|||||||||
2020 |
|
2019 |
|
2020 |
|
2019 |
|||||
|
|||||||||||
Agricultural net sales ($ in thousands) |
$ |
41,595 |
|
$ |
32,851 |
|
$ |
180,036 |
|
$ |
187,641 |
|
|
|
|
|
|
|
|
||||
Less freight |
|
4,328 |
|
|
3,956 |
|
|
15,967 |
|
|
14,727 |
|
|
|
|
|
|
|
|
||||
Agricultural netback sales |
$ |
37,267 |
|
$ |
28,895 |
|
$ |
164,069 |
|
$ |
172,914 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210224005982/en/
Company Contact:
(405) 235-4546
Investor Contact:
Source: